SPONSOR
Sparrow Pharmaceuticals
Total Trials
2
Recruiting
2
Phases
Phase 2, Phase 1
Sparrow Pharmaceuticals is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Type 2 Diabetes, Cortisol Excess, Moderate Renal Impairment.
The trial portfolio spans Phase 2, Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Sparrow Pharmaceuticals
How many clinical trials has Sparrow Pharmaceuticals sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by Sparrow Pharmaceuticals, of which 2 are actively recruiting participants. These trials cover conditions including Type 2 Diabetes, Cortisol Excess, Moderate Renal Impairment. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Sparrow Pharmaceuticals research focus on?
Sparrow Pharmaceuticals clinical trials span Type 2 Diabetes, Cortisol Excess, Moderate Renal Impairment. The research pipeline includes Phase 2, Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Sparrow Pharmaceuticals clinical trial?
To participate in a Sparrow Pharmaceuticals trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Sparrow Pharmaceuticals trials with current recruitment status updated daily.
Clinical Trials by Sparrow Pharmaceuticals
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology